Moderate riskFDA DeviceClass II

Bisaf Strep A Self-Test recalled for lack of FDA clearance

Altruan GmbH distributed Bisaf Strep A Self-Test kits without FDA clearance. This test is designed to detect group A streptococcal antigens in throat swabs, but has not been reviewed or approved by the FDA for safety and effectiveness. About 188 units were distributed nationwide.

From the FDA notice · Read the official notice ↗

What to do

  1. Stop using the Bisaf Strep A Self-Test immediately
  2. Do not rely on results from this test for medical decisions
  3. Contact your doctor for proper strep throat testing if you have symptoms
  4. If you have this test, contact the seller or Altruan GmbH for instructions on return or disposal

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Brand Name: Bisaf Strep A Self-Test. Test for detection of group A streptococcal antigens in throat swabs.
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 3 products — see all of them.

Details

Units affected
188 units
Illnesses reported
None reported
Manufactured in
Morolding 6, N/A, Massing, N/A, Germany
Classification
Class II
Recall number
Z-1561-2026

In the FDA's words

Description
Brand Name: Bisaf Strep A Self-Test. Test for detection of group A streptococcal antigens in throat swabs. Product not cleared by the FDA. Model No. AL-42153; No UDI; Lot Code: 6952804827274. Distribution: US Nationwide distribution. Affected quantity: 188 units
Hazard
Product not cleared by the FDA.

3 products in this recall

Altruan Strep A tests recalled for lacking FDA clearance

Altruan is recalling three Strep A test products, including the Wondfo Streptococcal A At-Home Self-Test, Clearest Strep-A Cassette Test, and Bisaf Strep A Self-Test. The tests were distributed nationwide and the FDA has not cleared them. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics